REVOLUTION MEDICINES INC (RVMD) Stock Income Statement
NASDAQ:RVMD - Nasdaq - US76155X1000 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 11.58M | 35.38M | 29.39M | 42.98M | |||
| Operating Expenses | 689.52M | 498.76M | 293.66M | 217.40M | 153.68M | |||
| Research and Development | 592.23M | 423.14M | 253.07M | 186.95M | 132.25M | |||
| Selling, General, and Administrative Expenses | 97.30M | 75.62M | 40.59M | 30.45M | 21.43M | |||
| Operating Income | -689.52M | -487.19M | -258.28M | -188.01M | -110.70M | |||
| Interest Income/Expense | 86.88M | 47.18M | 9.15M | 920.00K | 2.17M | |||
| Other Income/Expense | 1.79M | 115.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -600.85M | -439.89M | -249.13M | -187.09M | -108.53M | |||
| Income Tax | -753.00K | -3.52M | -420.00K | 0.00 | -370.00K | |||
| Net Income | -600.09M | -436.37M | -248.71M | -187.09M | -110.38M | |||
| EBITDA | -681.90M | -481.07M | -253.24M | -183.86M | -107.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.58 | -3.86 | -3.08 | -2.57 | -2.01 | |||
| Non GAAP EPS | -3.57 | -3.77 | -3.10 | -2.56 | -2.14 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -3768.28% | -702.97% | -636.58% | -256.82% | |||
| Operating Profit Margin | N/A | -4207.12% | -730.02% | -639.71% | -257.56% | |||
All data in USD